Incyte Corp (INCY)
51.73
+0.08
(+0.15%)
USD |
NASDAQ |
Apr 24, 16:00
51.73
0.00 (0.00%)
After-Hours: 19:51
Incyte Free Cash Flow (Quarterly): 145.46M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 145.46M |
| September 30, 2023 | 136.86M |
| June 30, 2023 | 299.19M |
| March 31, 2023 | -132.51M |
| December 31, 2022 | 262.39M |
| September 30, 2022 | 268.57M |
| June 30, 2022 | 162.41M |
| March 31, 2022 | 198.74M |
| December 31, 2021 | 80.89M |
| September 30, 2021 | 222.94M |
| June 30, 2021 | 106.64M |
| March 31, 2021 | 158.01M |
| December 31, 2020 | 55.89M |
| September 30, 2020 | 129.29M |
| June 30, 2020 | 225.52M |
| March 31, 2020 | -722.68M |
| December 31, 2019 | 102.30M |
| September 30, 2019 | 287.23M |
| June 30, 2019 | 105.67M |
| March 31, 2019 | 137.40M |
| December 31, 2018 | 58.56M |
| September 30, 2018 | 174.33M |
| June 30, 2018 | 21.61M |
| March 31, 2018 | 8.248M |
| December 31, 2017 | -114.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 18.82M |
| June 30, 2017 | 86.30M |
| March 31, 2017 | -194.60M |
| December 31, 2016 | 78.51M |
| September 30, 2016 | 78.64M |
| June 30, 2016 | -64.64M |
| March 31, 2016 | 91.97M |
| December 31, 2015 | 65.98M |
| September 30, 2015 | -5.635M |
| June 30, 2015 | 11.19M |
| March 31, 2015 | -8.139M |
| December 31, 2014 | 38.86M |
| September 30, 2014 | 17.13M |
| June 30, 2014 | -23.26M |
| March 31, 2014 | -34.36M |
| December 31, 2013 | -13.72M |
| September 30, 2013 | -12.74M |
| June 30, 2013 | 7.528M |
| March 31, 2013 | 23.84M |
| December 31, 2012 | -22.94M |
| September 30, 2012 | -27.55M |
| June 30, 2012 | 7.717M |
| March 31, 2012 | -54.90M |
| December 31, 2011 | -40.77M |
| September 30, 2011 | -48.16M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-722.68M
Minimum
Mar 2020
299.19M
Maximum
Jun 2023
110.15M
Average
145.46M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Novartis AG | 1.764B |
| MorphoSys AG | -- |
| Illumina Inc | 173.00M |
| Biogen Inc | -52.70M |
| Pfizer Inc | 4.196B |